nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—ALB—Furosemide—dilated cardiomyopathy	0.0632	1	CbGbCtD
Sucralfate—FGB—heart—dilated cardiomyopathy	0.0102	0.264	CbGeAlD
Sucralfate—FGA—heart—dilated cardiomyopathy	0.00874	0.226	CbGeAlD
Sucralfate—EGF—heart—dilated cardiomyopathy	0.00638	0.165	CbGeAlD
Sucralfate—FGF2—heart—dilated cardiomyopathy	0.00563	0.146	CbGeAlD
Sucralfate—EGF—cardiac atrium—dilated cardiomyopathy	0.00546	0.141	CbGeAlD
Sucralfate—ALB—heart—dilated cardiomyopathy	0.00221	0.0571	CbGeAlD
Sucralfate—FGF2—Cardiac Hypertrophic Response—TNF—dilated cardiomyopathy	0.000639	0.000711	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—RAC1—dilated cardiomyopathy	0.000633	0.000704	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—RAC1—dilated cardiomyopathy	0.000633	0.000704	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	0.000632	0.000704	CbGpPWpGaD
Sucralfate—EGF—ErbB1 downstream signaling—EGFR—dilated cardiomyopathy	0.000632	0.000703	CbGpPWpGaD
Sucralfate—EGF—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—dilated cardiomyopathy	0.000632	0.000703	CbGpPWpGaD
Sucralfate—FGA—Disease—NPPA—dilated cardiomyopathy	0.000629	0.0007	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—RAC1—dilated cardiomyopathy	0.000623	0.000694	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—RAC1—dilated cardiomyopathy	0.000615	0.000685	CbGpPWpGaD
Sucralfate—FGA—Disease—PSEN2—dilated cardiomyopathy	0.000609	0.000678	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—RAF1—dilated cardiomyopathy	0.000607	0.000675	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—RAF1—dilated cardiomyopathy	0.000607	0.000675	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—RAF1—dilated cardiomyopathy	0.000607	0.000675	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—RAF1—dilated cardiomyopathy	0.000601	0.000669	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	0.000596	0.000663	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000594	0.000661	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—RAF1—dilated cardiomyopathy	0.000593	0.00066	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—RAC1—dilated cardiomyopathy	0.000579	0.000645	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—RAC1—dilated cardiomyopathy	0.000579	0.000645	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000576	0.000641	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—RAF1—dilated cardiomyopathy	0.000573	0.000638	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000571	0.000635	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000556	0.000619	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000545	0.000606	CbGpPWpGaD
Sucralfate—FGF2—Signaling by Insulin receptor—RAF1—dilated cardiomyopathy	0.000538	0.000599	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	0.000537	0.000598	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000531	0.000591	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.000523	0.000582	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000515	0.000573	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000508	0.000565	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000507	0.000565	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000506	0.000564	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000506	0.000564	CbGpPWpGaD
Sucralfate—EGF—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	0.000499	0.000555	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—ITGB1—dilated cardiomyopathy	0.000491	0.000547	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	0.000477	0.000531	CbGpPWpGaD
Sucralfate—EGF—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000477	0.000531	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB4—EGFR—dilated cardiomyopathy	0.00047	0.000523	CbGpPWpGaD
Sucralfate—FGF2—Constitutive PI3K/AKT Signaling in Cancer—EGFR—dilated cardiomyopathy	0.000469	0.000522	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	0.00046	0.000513	CbGpPWpGaD
Sucralfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—TNF—dilated cardiomyopathy	0.000455	0.000507	CbGpPWpGaD
Sucralfate—EGF—Downstream signal transduction—EGFR—dilated cardiomyopathy	0.000449	0.0005	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR—EGFR—dilated cardiomyopathy	0.000446	0.000497	CbGpPWpGaD
Sucralfate—EGF—EGF/EGFR Signaling Pathway—EGFR—dilated cardiomyopathy	0.000446	0.000497	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB2—EGFR—dilated cardiomyopathy	0.000444	0.000495	CbGpPWpGaD
Sucralfate—EGF—DAP12 signaling—EGFR—dilated cardiomyopathy	0.000442	0.000492	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—RAF1—dilated cardiomyopathy	0.000441	0.00049	CbGpPWpGaD
Sucralfate—FGF2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000441	0.00049	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000438	0.000488	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000436	0.000485	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000435	0.000485	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	0.000434	0.000483	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—RAF1—dilated cardiomyopathy	0.000434	0.000483	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—RAF1—dilated cardiomyopathy	0.000428	0.000477	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000426	0.000475	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000426	0.000475	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000425	0.000473	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000423	0.000471	CbGpPWpGaD
Sucralfate—FGF2—PI-3K cascade—EGFR—dilated cardiomyopathy	0.000422	0.00047	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000422	0.000469	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—RAF1—dilated cardiomyopathy	0.000419	0.000467	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—RAF1—dilated cardiomyopathy	0.000419	0.000467	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—CD36—dilated cardiomyopathy	0.000419	0.000466	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—EGFR—dilated cardiomyopathy	0.000416	0.000463	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	0.000416	0.000463	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	0.000416	0.000463	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—RAF1—dilated cardiomyopathy	0.000414	0.000461	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—RAF1—dilated cardiomyopathy	0.000413	0.00046	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	0.000413	0.00046	CbGpPWpGaD
Sucralfate—FGF2—PI3K/AKT activation—EGFR—dilated cardiomyopathy	0.000412	0.000459	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—EGFR—dilated cardiomyopathy	0.000412	0.000459	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—RAF1—dilated cardiomyopathy	0.000412	0.000459	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—RAF1—dilated cardiomyopathy	0.00041	0.000456	CbGpPWpGaD
Sucralfate—FGF2—GAB1 signalosome—EGFR—dilated cardiomyopathy	0.000409	0.000455	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	0.000409	0.000455	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—RAF1—dilated cardiomyopathy	0.000408	0.000454	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—EGFR—dilated cardiomyopathy	0.000407	0.000453	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000403	0.000448	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000402	0.000448	CbGpPWpGaD
Sucralfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—dilated cardiomyopathy	0.0004	0.000445	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—RAC1—dilated cardiomyopathy	0.000395	0.00044	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—RAC1—dilated cardiomyopathy	0.000394	0.000439	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—EGFR—dilated cardiomyopathy	0.000393	0.000438	CbGpPWpGaD
Sucralfate—EGF—Disease—NPPA—dilated cardiomyopathy	0.000392	0.000437	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000391	0.000436	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000391	0.000436	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000387	0.00043	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000387	0.00043	CbGpPWpGaD
Sucralfate—EGF—B Cell Activation—EGFR—dilated cardiomyopathy	0.000385	0.000429	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—RAF1—dilated cardiomyopathy	0.000384	0.000427	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—RAF1—dilated cardiomyopathy	0.000384	0.000427	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—RAF1—dilated cardiomyopathy	0.000384	0.000427	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—RAF1—dilated cardiomyopathy	0.00038	0.000424	CbGpPWpGaD
Sucralfate—EGF—Disease—PSEN2—dilated cardiomyopathy	0.00038	0.000423	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000379	0.000422	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000379	0.000422	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000379	0.000422	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000379	0.000422	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CD36—dilated cardiomyopathy	0.000377	0.00042	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	0.000377	0.00042	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—RAF1—dilated cardiomyopathy	0.000375	0.000418	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000373	0.000415	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	0.000368	0.00041	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000368	0.00041	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000362	0.000403	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000361	0.000402	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000359	0.0004	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—RAC1—dilated cardiomyopathy	0.000355	0.000396	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000352	0.000392	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000352	0.000392	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000348	0.000387	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000341	0.00038	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000341	0.00038	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000341	0.00038	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	0.00034	0.000379	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000317	0.000353	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	0.000316	0.000352	CbGpPWpGaD
Sucralfate—FGA—Disease—RAC1—dilated cardiomyopathy	0.000306	0.000341	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TTN—dilated cardiomyopathy	0.000306	0.000341	CbGpPWpGaD
Sucralfate—FGF2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000302	0.000336	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	0.000302	0.000336	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—EGFR—dilated cardiomyopathy	0.000297	0.000331	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000297	0.000331	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000291	0.000324	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000291	0.000324	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—EGFR—dilated cardiomyopathy	0.000284	0.000316	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000283	0.000315	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—EGFR—dilated cardiomyopathy	0.000283	0.000315	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000282	0.000314	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—EGFR—dilated cardiomyopathy	0.000281	0.000313	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—EGFR—dilated cardiomyopathy	0.00028	0.000312	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000276	0.000308	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000276	0.000308	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000276	0.000307	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—CD36—dilated cardiomyopathy	0.00027	0.000301	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000269	0.000299	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000266	0.000296	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	0.000266	0.000296	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000265	0.000295	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—EGFR—dilated cardiomyopathy	0.000263	0.000293	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	0.000263	0.000293	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	0.000263	0.000293	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—RAF1—dilated cardiomyopathy	0.000262	0.000291	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—RAF1—dilated cardiomyopathy	0.000262	0.000291	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—EGFR—dilated cardiomyopathy	0.000261	0.00029	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	0.000259	0.000288	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000258	0.000287	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000258	0.000287	CbGpPWpGaD
Sucralfate—EGF—Immune System—ITGB1—dilated cardiomyopathy	0.000258	0.000287	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—EGFR—dilated cardiomyopathy	0.000257	0.000287	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—RAC1—dilated cardiomyopathy	0.000255	0.000284	CbGpPWpGaD
Sucralfate—FGF2—Disease—NPPA—dilated cardiomyopathy	0.000248	0.000277	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000248	0.000276	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000247	0.000275	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—EGFR—dilated cardiomyopathy	0.000244	0.000271	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000242	0.00027	CbGpPWpGaD
Sucralfate—FGF2—Disease—PSEN2—dilated cardiomyopathy	0.000241	0.000268	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00024	0.000267	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CD36—dilated cardiomyopathy	0.000239	0.000266	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000237	0.000264	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000237	0.000264	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000236	0.000263	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000236	0.000263	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000236	0.000263	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—RAF1—dilated cardiomyopathy	0.000236	0.000262	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	0.000233	0.00026	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000229	0.000255	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000226	0.000252	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—VCL—dilated cardiomyopathy	0.000226	0.000251	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—RAC1—dilated cardiomyopathy	0.000225	0.00025	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00022	0.000245	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD36—dilated cardiomyopathy	0.00022	0.000245	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000219	0.000244	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000216	0.00024	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000214	0.000239	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000214	0.000239	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000213	0.000237	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—AGT—dilated cardiomyopathy	0.000209	0.000233	CbGpPWpGaD
Sucralfate—EGF—Immune System—RAC1—dilated cardiomyopathy	0.000207	0.00023	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—AGT—dilated cardiomyopathy	0.000205	0.000228	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—AGT—dilated cardiomyopathy	0.000205	0.000228	CbGpPWpGaD
Sucralfate—FGA—Disease—RAF1—dilated cardiomyopathy	0.000203	0.000226	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	0.000201	0.000224	CbGpPWpGaD
Sucralfate—EGF—Disease—RAC1—dilated cardiomyopathy	0.000191	0.000213	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000188	0.000209	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000182	0.000202	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000179	0.0002	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000177	0.000197	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	0.000174	0.000194	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000172	0.000192	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—RAF1—dilated cardiomyopathy	0.000169	0.000188	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000168	0.000188	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TAZ—dilated cardiomyopathy	0.000164	0.000182	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ITGB1—dilated cardiomyopathy	0.000163	0.000181	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—EGFR—dilated cardiomyopathy	0.000162	0.00018	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00016	0.000178	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000155	0.000173	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00015	0.000167	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00015	0.000167	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—RAF1—dilated cardiomyopathy	0.000149	0.000166	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SDHA—dilated cardiomyopathy	0.000148	0.000165	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000148	0.000165	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000145	0.000162	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000143	0.000159	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000142	0.000158	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000142	0.000158	CbGpPWpGaD
Sucralfate—FGA—Disease—EGFR—dilated cardiomyopathy	0.000139	0.000155	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000139	0.000155	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD36—dilated cardiomyopathy	0.000139	0.000155	CbGpPWpGaD
Sucralfate—EGF—Immune System—RAF1—dilated cardiomyopathy	0.000137	0.000153	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000135	0.00015	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000134	0.000149	CbGpPWpGaD
Sucralfate—FGF2—Immune System—RAC1—dilated cardiomyopathy	0.000131	0.000146	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AGT—dilated cardiomyopathy	0.000128	0.000142	CbGpPWpGaD
Sucralfate—EGF—Disease—RAF1—dilated cardiomyopathy	0.000127	0.000141	CbGpPWpGaD
Sucralfate—FGF2—Disease—RAC1—dilated cardiomyopathy	0.000121	0.000135	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000117	0.00013	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EGFR—dilated cardiomyopathy	0.000116	0.000129	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000115	0.000128	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	0.000113	0.000126	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TNF—dilated cardiomyopathy	0.00011	0.000123	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000109	0.000121	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EGFR—dilated cardiomyopathy	0.000102	0.000114	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EGFR—dilated cardiomyopathy	9.95e-05	0.000111	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—EGFR—dilated cardiomyopathy	9.82e-05	0.000109	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EGFR—dilated cardiomyopathy	9.75e-05	0.000109	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EGFR—dilated cardiomyopathy	9.75e-05	0.000109	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—CD36—dilated cardiomyopathy	9.67e-05	0.000108	CbGpPWpGaD
Sucralfate—EGF—Immune System—EGFR—dilated cardiomyopathy	9.41e-05	0.000105	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.38e-05	0.000104	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—RAC1—dilated cardiomyopathy	9.11e-05	0.000101	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.04e-05	0.000101	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—RAF1—dilated cardiomyopathy	8.87e-05	9.88e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.8e-05	9.8e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—EGFR—dilated cardiomyopathy	8.69e-05	9.68e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—RAF1—dilated cardiomyopathy	8.69e-05	9.67e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RAC1—dilated cardiomyopathy	8.47e-05	9.43e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AGT—dilated cardiomyopathy	8.09e-05	9.01e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—RAF1—dilated cardiomyopathy	8.02e-05	8.93e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.92e-05	8.82e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EGFR—dilated cardiomyopathy	6.09e-05	6.78e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—RAF1—dilated cardiomyopathy	6.04e-05	6.73e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EGFR—dilated cardiomyopathy	5.96e-05	6.63e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RAF1—dilated cardiomyopathy	5.62e-05	6.25e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—EGFR—dilated cardiomyopathy	5.5e-05	6.12e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.23e-05	5.82e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GPX1—dilated cardiomyopathy	4.02e-05	4.48e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CD36—dilated cardiomyopathy	3.92e-05	4.36e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.85e-05	4.29e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AGT—dilated cardiomyopathy	3.53e-05	3.93e-05	CbGpPWpGaD
